Back to Journals » Lung Cancer: Targets and Therapy » Volume 8

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Total article views   HTML views PDF downloads Totals
9,767 Dovepress* 8,407+ 1,077 9,484
PubMed Central* 1,360 361 1,721
Totals 9,767 1,438 11,205
*Since 19 October 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar